Nebula Research & Development LLC Has $2.19 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Nebula Research & Development LLC boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 182.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,867 shares of the medical device company's stock after buying an additional 15,406 shares during the period. Nebula Research & Development LLC's holdings in Cooper Companies were worth $2,194,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its stake in Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after purchasing an additional 2,957,421 shares in the last quarter. Norges Bank purchased a new position in Cooper Companies in the fourth quarter valued at about $217,906,000. FMR LLC grew its stake in Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after purchasing an additional 1,095,805 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Cooper Companies in the fourth quarter valued at about $64,826,000. Finally, Victory Capital Management Inc. grew its stake in Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

COO stock traded down $1.31 on Wednesday, reaching $80.92. 483,739 shares of the company were exchanged, compared to its average volume of 1,419,776. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The stock's fifty day moving average price is $81.91 and its 200 day moving average price is $92.34. The firm has a market capitalization of $16.18 billion, a PE ratio of 41.50, a PEG ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Robert W. Baird decreased their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. JPMorgan Chase & Co. lowered their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.